Dr Dina Nair
Dr Dina Nair
Designation: Scientist E
Division/Unit: Clinical Research
Email: dina[dot]nair[at]icmr[dot]gov[dot]in
Educational Qualification
MBBS, MPH
Personal Statement
Dr. Dina Nair is a clinician and public health researcher who graduated from the Government Medical College, Thiruvananthapuram. She has over 19 years of experience in tuberculosis (TB) research and program implementation. Her work focuses on clinical and implementation research in the field of TB. Her main areas of interest include TB prevention and drug-resistant TB. She is also actively involved in projects aimed at shortening the duration of treatment for TB and improving early diagnosis and treatment adherence. She remains committed to contributing to TB control efforts through research and collaboration, to support better patient outcomes and strengthen public health programs.
Research Focus
- • TB preventive therapy
- • Drug resistant TB
Ongoing projects as Principal investigator
Comprehensive intervention strategy to improve retention in TB infection cascade of care in high-risk groups through a person-centered approach in the SEAR countries (CRITIC)
Significant Publications
1) Nair D, Velayutham B, Kannan T, Tripathy JP, Harries AD, Natrajan M, Swaminathan S. Predictors of unfavourable treatment outcome in patients with multidrug-resistant tuberculosis in India. Public Health Action. 2017 Mar 21;7(1):32-38. [Citation-79]
2) Nair D, Rajshekhar N, Klinton JS, Watson B, Velayutham B, Tripathy JP, et al. (2016) Household Contact Screening and Yield of Tuberculosis Cases —A Clinic Based Study in Chennai, South India. PLoS ONE 11(9): e0162090 [Citation-73]
3) Nathella Pavan Kumar, Kadar Moideen, Vaithilingam V Banurekha, Dina Nair, Subash Babu, Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis, Open Forum Infectious Diseases, Volume 6, Issue 7, July 2019 [Citation-129]
4) Kumar NP, Sridhar R, Nair D, Banurekha VV, Nutman TB, Babu S. Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis. Immunology. 2015 Apr;144(4):677-86. doi: 10.1111/imm.12421. PMID: 25363329; PMCID: PMC4368174. [Citation-111]
5) Dina Nair, Pooranaganga D. Navneethapandian, Jaya Prasad Tripathy, Anthony D. Harries, Joel S. Klinton, Basilea Watson, Gomathi N. Sivaramakrishnan, Devarajulu S. Reddy, Lakshmi Murali, Mohan Natrajan, Soumya Swaminathan, Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil Nadu, India, Transactions of The Royal Society of Tropical Medicine and Hygiene, Volume 110, Issue 9, September 2016, Pages 534–541[Citation-30]
6) Velayutham BV, Allaudeen IS, Sivaramakrishnan GN, Perumal V, Nair D, Chinnaiyan P, Paramasivam PK, Dhanaraj B, Santhanakrishnan RK, Navaneethapandian GP, et al. Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India. Clin Infect Dis. 2014 Nov 15;59(10):e142-9. doi: 10.1093/cid/ciu550. Epub 2014 Jul 14. PMID: 25028463. [Citation-25]
7) Thomas BE, Velayutham B, Thiruvengadam K, Nair D, Barman SB, Jayabal L, et al. (2016) Perceptions of Private Medical Practitioners on Tuberculosis Notification: A Study from Chennai, South India. PLoS ONE 11(1): e0147579. [Citation-59]
8) Mahapatra, A., Thiruvengadam, K., Nair, D., Padmapriyadarsini, C., Thomas, B., Pati, S., Bulliyya, G., Das, D., Chowdhury, J., Bang, A., & Swaminathan, S. (2024). Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach. PLOS ONE, 19(7), e0305855. [Citation-14]
9) Munir A, Kumar N, Ramalingam SB, Tamilzhalagan S, Shanmugam SK, Palaniappan AN, Nair D, Priyadarshini P, Natarajan M, Tripathy S, Ranganathan UD, Peacock SJ, Parkhill J, Blundell TL, Malhotra S. Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India. Sci Rep. 2019 Jul 16;9(1):10283[Citation-53]
10) Velayutham B, Nair D, Kannan T, Padmapriyadarsini C, Sachdeva KS, Bency J, Klinton JS, Haldar S, Khanna A, Jayasankar S, Swaminathan S. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis. Int J Tuberc Lung Dis. 2016 Dec;20(12):1671-1676. [Citation-44]
